Jane Street
HRMY icon

Jane Street’s Harmony Biosciences HRMY Stock Holding History

Jane Street’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81M Sell
77,100
-2,700
-3% -$85.2K ﹤0.01% 4615
2026
Q1 		$2.24M Sell
79,800
-21,900
-22% -$718K ﹤0.01% 4870
2025
Q4 		$3.81M Buy
101,700
+39,300
+63% +$1.29M ﹤0.01% 3665
2025
Q3 		$1.72M Buy
+62,400
New +$2.15M ﹤0.01% 5214
2024
Q3 		– Sell
-12,200
Closed -$368K – 9917
2024
Q2 		$368K Sell
12,200
-10,800
-47% -$325K ﹤0.01% 7483
2024
Q1 		$772K Buy
+23,000
New +$738K ﹤0.01% 5885
2023
Q3 		– Sell
-142,600
Closed -$5.02M – 8932
2023
Q2 		$5.02M Sell
142,600
-8,600
-6% -$297K ﹤0.01% 2732
2023
Q1 		$4.94M Buy
+151,200
New +$6.89M ﹤0.01% 2485

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's HRMY Position: Q2 2026 in Review

Jane Street sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 9,993 shares — an estimated $315K sold.

Jane Street first reported a position in HRMY in Q1 2022 and held it in 14 quarters. The position peaked at $8.29M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jane Street reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 9,993 Harmony Biosciences shares in Q2 2026, an estimated $315K.
  • Jane Street first reported a position in Harmony Biosciences in Q1 2022 and held it in 14 quarters.
  • Jane Street's Harmony Biosciences position peaked at $8.29M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.